Haemoxigenase (heme oxygenase, HO) is the rate-limiting enzyme that catalyses the oxidative cleavage of heme—the iron-containing porphyrin ring found in haemoglobin and other heme proteins—into three products: biliverdin (a green pigment), free ferrous iron (Fe²⁺), and carbon monoxide (CO). This reaction occurs primarily in spleen macrophages (which process senescent red blood cells) and hepatocytes. Two isoforms exist: HO-1 (inducible, stress-responsive, cytoprotective) and HO-2 (constitutively expressed in brain and testes).
Imagine haemoxigenase as the recycling plant at a car scrapyard, specifically tasked with dismantling old red cars (haemoglobin molecules). When a worn-out red car arrives, the plant uses heavy-duty shears to cut open the metal frame (the porphyrin ring). This releases three salvageable components: (1) green paint chips (biliverdin), which get further processed into yellow paint (bilirubin) by a downstream worker (biliverdin reductase); (2) the iron engine block (Fe²⁺), which is immediately locked in a secure storage container (ferritin) so it doesn't rust or cause damage; and (3) exhaust fumes (carbon monoxide), which surprisingly act as a gentle smoke signal to nearby buildings, telling blood vessels to relax and inflammation to calm down. The plant has two shifts: Shift HO-1 only shows up during emergencies—fires, toxic spills, heavy metal contamination—when oxidative stress is high (hormetic responders needed). Shift HO-2 runs 24/7 in the brain and testes, quietly maintaining housekeeping duties. Crucially, the yellow paint (bilirubin) produced here doesn't just get thrown away—it travels to the gut via bile, where bacteria strip off its water-soluble coating, transforming it into a molecular off-switch for digestive enzymes in the colon, preventing pancreatic enzymes from digesting your own intestinal wall.
Heme + 3O₂ + 7e⁻ (from NADPH-cytochrome P450 reductase) → biliverdin + Fe²⁺ + CO
Haemoxigenase cleaves the α-methene bridge of the porphyrin ring (between pyrrole rings A and B), requiring molecular oxygen and electrons from NADPH. The reaction proceeds in three monooxygenation steps, producing:
- Biliverdin (green pigment) — immediately reduced to bilirubin by biliverdin reductase
- Fe²⁺ — sequestered by ferritin (preventing Fenton chemistry and hydroxyl radical formation)
- Carbon monoxide (CO) — a gasotransmitter with vasodilatory and anti-inflammatory signalling functions (similar to nitric oxide)
-
HO-1 (inducible, 32 kDa, chromosome 22q12)
- Basal expression low; massively upregulated by:
- Oxidative stress (H₂O₂, superoxide)
- Heme accumulation (substrate induction)
- Heavy metals (cadmium, arsenic)
- Hypoxia (via HIF-1α)
- Inflammatory cytokines (IL-1β, TNF-α)
- Heat shock
- Transcriptional control via Nrf2 → ARE (antioxidant response element) in HO-1 promoter
- Cytoprotective: neutralises heme toxicity, produces antioxidant bilirubin, generates anti-inflammatory CO
-
HO-2 (constitutive, 36 kDa, chromosome 16p13.3)
- Abundant in brain (neurons, glia), testes, endothelial cells
- Regulated by glucocorticoids, NO, heme binding
- Functions in normal heme turnover, neuronal signalling (CO acts as neurotransmitter)
graph TD
A[Heme in senescent RBCs] -->|Macrophage phagocytosis| B[Spleen macrophages]
B -->|Haemoxigenase HO-1| C["Biliverdin + Fe²⁺ + CO"]
C -->|Biliverdin reductase| D[Unconjugated bilirubin]
D -->|Albumin carrier| E[Hepatocytes]
E -->|UGT1A1 phase 2 conjugation| F[Conjugated bilirubin-diglucuronide]
F -->|Bile secretion| G[Duodenum]
G -->|"Gut bacteria β-glucuronidase"| H[Deconjugated bilirubin]
H -->|"Urobilinogen → stercobilin"| I[Colon]
I -->|Inactivates pancreatic enzymes| J[Prevents colonic autodigestion]
C -->|"Fe²⁺"| K[Ferritin storage]
C -->|CO| L["Vasodilation + anti-inflammatory signalling"]
CO → binds soluble guanylyl cyclase (sGC) → ↑ cGMP → protein kinase G activation → vasodilation, anti-platelet effects, anti-apoptotic signalling
CO also S-nitrosylates cysteine residues on NF-κB, inhibiting pro-inflammatory transcription.
- Antioxidant: Unconjugated bilirubin scavenges peroxyl radicals, singlet oxygen; recycled via biliverdin reductase (redox cycling)
- Digestive enzyme regulator: Deconjugated bilirubin in colon → inactivates trypsin, chymotrypsin, elastase (preventing colonic inflammation from pancreatic enzyme spillover)
- HO-1 promoter (GT)n repeat polymorphisms: Longer (GT)n repeats → lower HO-1 inducibility → associated with:
- Crohn's disease susceptibility (reduced capacity to manage oxidative stress and regulate digestive enzymes in colon)
- Coronary artery disease
- Emphysema
¶ Crohn's Disease and Digestive Enzyme Regulation
Haemoxigenase deficiency—specifically HO-1 promoter SNPs with long (GT)n repeats—is overrepresented in Crohn's disease patients. The mechanism ties to the Berner Hypothesis: pancreatic enzymes (trypsin, chymotrypsin, elastase) normally travel through the small intestine and remain active into the colon. Without sufficient bilirubin production and deconjugation by gut bacteria, these proteases continue digesting colonic mucosa → chronic inflammation, ulceration, fibrosis. This represents a breakdown in the Phase 0 metamodel (barrier integrity) and metabolic system failure (loss of metabolic flexibility in heme processing).
Clinical intervention:
- Curcumin (500-1500 mg/day): Upregulates UGT1A1 (phase 2 conjugation enzyme), supports bile flow, enhances bacterial β-glucuronidase activity
- Allicin (garlic extract): Modulates gut microbiota to improve bilirubin deconjugation
- HO-1 inducers: Resveratrol, quercetin, sulforaphane (via Nrf2 activation)
¶ Oxidative Stress and Hormesis
HO-1 is the canonical hormetic enzyme: mild oxidative stress → Nrf2 nuclear translocation → HO-1 transcription → increased antioxidant capacity (bilirubin), reduced free heme toxicity, anti-inflammatory CO signalling. This fits the 5+2 metamodel: controlled oxidative stressors (exercise, cold exposure, hypoxia, fasting) → adaptive HO-1 upregulation → metabolic resilience.
Dysregulation: Chronic HO-1 suppression (genetic, nutritional deficiencies, chronic inflammation) → accumulation of free heme → Fenton chemistry → lipid peroxidation → endothelial dysfunction, atherosclerosis, neurodegeneration.
CO from haemoxigenase parallels nitric oxide and hydrogen sulfide: all three are gases produced enzymatically with signalling roles. CO at physiological concentrations (10-40 ppm endogenous) → vasodilation, anti-inflammatory macrophage polarisation (M2 shift), cytoprotection. This explains why therapeutic CO inhalation (250 ppm for 1 hour) shows promise in ARDS, sepsis, organ transplantation.
¶ Iron Recycling and Anemia of Inflammation
Haemoxigenase releases Fe²⁺ from heme → stored in ferritin → regulated release via ferroportin. In chronic inflammation, hepcidin blocks ferroportin → iron trapped in macrophages → anemia of chronic disease (functional iron deficiency despite adequate stores). This represents selfish immune system prioritising pathogen sequestration over erythropoiesis.
Excess unconjugated bilirubin (>20 mg/dL in neonates) → crosses blood-brain barrier → neurotoxic (binds neuronal membranes, disrupts mitochondrial respiration). HO-1 overactivity (e.g., neonatal haemolysis) without adequate hepatic conjugation capacity → clinical emergency. This highlights the importance of phase 2 detoxification capacity matching phase 0/1 load.
The dual heme toxicity / bilirubin antioxidant system reflects antagonistic pleiotropy: high haemoxigenase activity protects against oxidative stress in youth but may contribute to hyperbilirubinaemia complications in vulnerable states (neonates, liver dysfunction). The digestive enzyme regulation function likely evolved as humans transitioned to higher protein diets (hunting), requiring tighter control of proteolytic activity in the colon.
- Catalytic reaction: Heme → biliverdin (via α-methene bridge cleavage) → bilirubin (via biliverdin reductase) + Fe²⁺ + CO
- Two isoforms: HO-1 (inducible, stress-responsive, 32 kDa) and HO-2 (constitutive, neuronal/testicular, 36 kDa)
- Primary locations: Spleen macrophages (RBC recycling), liver hepatocytes (bilirubin conjugation), brain neurons (CO signalling)
- HO-1 inducers: Oxidative stress, heme, hypoxia (HIF-1α), heavy metals, cytokines (TNF-α, IL-1β), curcumin, resveratrol, sulforaphane
- CO signalling: 10-40 ppm endogenous; activates soluble guanylyl cyclase → ↑ cGMP → vasodilation, anti-inflammation
- Bilirubin threshold: >1.2 mg/dL conjugated (direct) or >20 mg/dL unconjugated (indirect) in adults = pathological; >20 mg/dL in neonates = kernicterus risk
- Crohn's association: HO-1 promoter (GT)n repeat polymorphism (>30 repeats) → reduced enzyme inducibility → impaired digestive enzyme regulation
- Ferritin role: Sequesters Fe²⁺ released by haemoxigenase; prevents Fenton reaction (Fe²⁺ + H₂O₂ → hydroxyl radicals)
- Bilirubin antioxidant capacity: Scavenges peroxyl radicals at 10 µM; recycled by biliverdin reductase (10-fold amplification)
- Curcumin mechanism: Upregulates UGT1A1 (phase 2 conjugation), enhances bile secretion, modulates gut bacterial β-glucuronidase
- haemoglobin — haemoxigenase breaks down the heme prosthetic group from senescent haemoglobin molecules
- bilirubin — haemoxigenase produces biliverdin, which is immediately reduced to bilirubin by biliverdin reductase
- biliverdin — the direct enzymatic product of haemoxigenase before reduction to bilirubin
- iron — haemoxigenase liberates Fe²⁺ from heme; sequestered by ferritin to prevent oxidative damage
- ferritin — stores the Fe²⁺ released by haemoxigenase, preventing free iron toxicity and Fenton chemistry
- carbon monoxide — gasotransmitter byproduct of haemoxigenase; vasodilatory and anti-inflammatory signalling molecule
- spleen — primary site of haemoxigenase activity in macrophages recycling senescent RBCs (120-day lifespan)
- liver — hepatocytes use haemoxigenase to process heme and conjugate bilirubin via UGT1A1 (phase 2 detoxification)
- oxidative stress — potent inducer of HO-1 via Nrf2-ARE pathway; hormetic adaptation to ROS
- Nrf2 — transcription factor that binds antioxidant response elements (ARE) in HO-1 promoter, upregulating expression
- digestive enzymes — deconjugated bilirubin from haemoxigenase inactivates trypsin, chymotrypsin, elastase in colon
- Crohn's disease — HO-1 promoter SNP (long GT repeats) → reduced enzyme inducibility → inadequate digestive enzyme shut-off
- inflammation — CO from haemoxigenase inhibits NF-κB, promotes M2 macrophage polarisation, reduces TNF-α
- bile — conjugated bilirubin transported from liver to duodenum via bile; deconjugated by gut bacteria
- phase 2 detoxification — bilirubin undergoes glucuronidation (UGT1A1) in liver after haemoxigenase produces unconjugated form
- curcumin — upregulates UGT1A1, supports bile flow, enhances gut bacterial β-glucuronidase for bilirubin deconjugation
- gut bacteria — bacterial β-glucuronidase deconjugates bilirubin in ileum/colon, enabling digestive enzyme inactivation
- Hormesis — HO-1 is archetypal hormetic enzyme: mild oxidative stress → adaptive upregulation → enhanced resilience
- HIF-1 — hypoxia-inducible factor 1α upregulates HO-1 transcription under low oxygen conditions
- nitric oxide — parallel gasotransmitter to CO; both activate sGC, produce cGMP, vasodilate, anti-inflammatory
- Reactive Oxygen Species — heme breakdown prevents ROS generation from free heme (Fenton chemistry); bilirubin scavenges ROS
- M2 macrophages — CO from haemoxigenase promotes anti-inflammatory M2 polarisation over pro-inflammatory M1
- anemia of chronic disease — haemoxigenase releases Fe²⁺, but hepcidin traps it in macrophages → functional iron deficiency
- TNF-α — induces HO-1 expression; HO-1-derived CO reciprocally inhibits TNF-α production (negative feedback)
- UGT1A1 — UDP-glucuronosyltransferase that conjugates bilirubin in phase 2; polymorphisms cause Gilbert syndrome
- kernicterus — unconjugated bilirubin neurotoxicity when haemoxigenase activity exceeds hepatic conjugation capacity
- β-glucuronidase — bacterial enzyme in gut that deconjugates bilirubin, enabling enzyme-inactivating function in colon
- atherosclerosis — chronic HO-1 deficiency → excess free heme → endothelial oxidative damage → plaque formation